COLUMBUS, OH--(Marketwire - January 07, 2010) -
Prologue is pleased to announce the arrival of
our new Vice President of Business Development. Art Ziegler brings with
him 25 years of clinical research and business development experience. As
Vice President of Business Development, his primary roles will include
securing levels of sustainable, profitable revenue necessary to meet the
company's financial objectives through effective sales and marketing
strategies, developing and implementing marketing and sales initiatives to
create awareness and demand for Prologue services within the oncology
clinical research community and identifying, and meeting key decision
makers of potential clients.
Prior to joining Prologue, Mr. Ziegler held various positions at
Pharmaceutical (Smithkline & French Laboratories), Biotech (Ortho Biotech -
JNJ), SMO (Florida Pharmaceutical Research) and CRO (Premier Research)
companies. Prologue wholeheartedly welcomes him to the team and looks
forward to his guidance as we continue to grow as "The Oncology CRO."
Prologue Research is a leading global oncology contract research
organization (CRO) founded in 1998. The Company offers a full range of
clinical research services for Phase I-IV international or
US-based clinical trials in oncology. Prologue provides its clients with
world-class experience, a deeply qualified staff, and state-of-the-art
systems uniquely designed for complicated oncology trials. We offer the
expertise, service and talent that enables our sponsors to make an impact
in the lives of people with cancer.
For more information about this appointment or to learn more about
Prologue's full range of oncology clinical trial services, please visit our
website at www.procro.com or email info@procro.com.
